Literature DB >> 29192662

Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder.

Anantha Shekhar1, Ganesh A Thakur2.   

Abstract

Entities:  

Year:  2018        PMID： 29192662      PMCID： PMC5719119          DOI： 10.1038/npp.2017.230

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

Review 1.  Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors:  Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal:  Psychoneuroendocrinology       Date:  2014-10-22       Impact factor: 4.905

2.  Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors.

Authors:  Robert H Pietrzak; Yiyun Huang; Stefani Corsi-Travali; Ming-Qiang Zheng; Shu-fei Lin; Shannan Henry; Marc N Potenza; Daniele Piomelli; Richard E Carson; Alexander Neumeister
Journal:  Neuropsychopharmacology       Date:  2014-05-12       Impact factor: 7.853

3.  Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.

Authors:  Richard A Slivicki; Zhili Xu; Pushkar M Kulkarni; Roger G Pertwee; Ken Mackie; Ganesh A Thakur; Andrea G Hohmann
Journal:  Biol Psychiatry       Date:  2017-07-08       Impact factor: 13.382

Review 4.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

5.  Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.

Authors:  Bradley V Watts; Paula P Schnurr; Lorna Mayo; Yinong Young-Xu; William B Weeks; Matthew J Friedman
Journal:  J Clin Psychiatry       Date:  2013-06       Impact factor: 4.384

6.  Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).

Authors:  Pushkar M Kulkarni; Abhijit R Kulkarni; Anisha Korde; Ritesh B Tichkule; Robert B Laprairie; Eileen M Denovan-Wright; Han Zhou; David R Janero; Nikolai Zvonok; Alexandros Makriyannis; Maria G Cascio; Roger G Pertwee; Ganesh A Thakur
Journal:  J Med Chem       Date:  2015-11-28       Impact factor: 7.446
  6 in total
  2 in total

1.  Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.

Authors:  Elise Wouters; Jolien Walraed; Michael Joseph Robertson; Max Meyrath; Martyna Szpakowska; Andy Chevigné; Georgios Skiniotis; Christophe Stove
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-04

Review 2.  Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development.

Authors:  Lu Hou; Jian Rong; Ahmed Haider; Daisuke Ogasawara; Cassis Varlow; Michael A Schafroth; Linjing Mu; Jiefeng Gan; Hao Xu; Christopher J Fowler; Ming-Rong Zhang; Neil Vasdev; Simon Ametamey; Benjamin F Cravatt; Lu Wang; Steven H Liang
Journal:  J Med Chem       Date:  2020-12-30       Impact factor: 7.446
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.